Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBIT: 2018-2025

Historic EBIT for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to -$11.5 million.

  • Evolus' EBIT rose 25.68% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.2 million, marking a year-over-year increase of 3.77%. This contributed to the annual value of -$34.4 million for FY2024, which is 30.11% up from last year.
  • Latest data reveals that Evolus reported EBIT of -$11.5 million as of Q3 2025, which was down 12.63% from -$10.2 million recorded in Q2 2025.
  • Over the past 5 years, Evolus' EBIT peaked at $8.0 million during Q1 2021, and registered a low of -$21.3 million during Q2 2022.
  • Moreover, its 3-year median value for EBIT was -$11.5 million (2025), whereas its average is -$11.0 million.
  • As far as peak fluctuations go, Evolus' EBIT soared by 146.14% in 2021, and later crashed by 292.47% in 2022.
  • Evolus' EBIT (MRQ) stood at -$18.0 million in 2021, then soared by 41.00% to -$10.6 million in 2022, then rose by 18.82% to -$8.6 million in 2023, then skyrocketed by 73.20% to -$2.3 million in 2024, then plummeted by 396.97% to -$11.5 million in 2025.
  • Its last three reported values are -$11.5 million in Q3 2025, -$10.2 million for Q2 2025, and -$15.2 million during Q1 2025.